STEC-HUS | |
 Infection with Shiga toxin–producing Escherichia coli or less frequently with Shigella dysenteriae. The most common cause of HUS in children. | |
TTP | |
 Deficiency of ADAMTS13 hereditary (Upshaw-Shulman syndrome) or acquired that causes by ADAMTS13 inhibitor. | |
aHUS, complement regulation abnormality | |
 Congenital | |
  Genetic mutations of complement proteins | |
 Acquired | |
  Autoantibodies against complement proteins, such as anti-factor H antibody | |
Secondary TMA | |
 Cobalamin metabolism disorder | |
 Drug-induced | |
  Chemotherapeutic agents (e.g., gemcitabine, mitomycin) | |
  Immunosuppressive agents (e.g., cyclosporine, tacrolimus) | |
  Antiplatelet agents (e.g., ticlopidine) | |
 Infection | |
  Pneumococcus, human immunodeficiency virus, pertussis, influenza, varicella | |
 Pregnancy-related | |
 Preeclampsia/eclampsia, hemolysis, elevated liver HELLP | |
 Auto-immune disease, collagen disease | |
 Systemic lupus erythematosus, systemic sclerosis, polymyositis/dermatomyositis | |
 Bone marrow transplant, organ transplant-related |